Qingchun Fu

1.3k total citations
22 papers, 594 citations indexed

About

Qingchun Fu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Qingchun Fu has authored 22 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Hepatology and 3 papers in Surgery. Recurrent topics in Qingchun Fu's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (8 papers) and Liver physiology and pathology (3 papers). Qingchun Fu is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (8 papers) and Liver physiology and pathology (3 papers). Qingchun Fu collaborates with scholars based in China, United Kingdom and Panama. Qingchun Fu's co-authors include Yinpeng Jin, Chengwei Chen, Xiaojin Wang, Ke Ning, Cheng‐Wei Chen, Jingbo Qie, Jun Xu, Xiutao Fu, Zhen‐Bin Ding and Lungen Lu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and World Journal of Gastroenterology.

In The Last Decade

Qingchun Fu

20 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingchun Fu China 12 210 200 170 111 107 22 594
Lianbao Kong China 17 98 0.5× 334 1.7× 154 0.9× 247 2.2× 195 1.8× 46 760
Melitta Penz-Österreicher United States 5 233 1.1× 256 1.3× 288 1.7× 68 0.6× 225 2.1× 6 773
Kang He China 18 158 0.8× 364 1.8× 115 0.7× 171 1.5× 106 1.0× 46 773
Akihiko Ohno Japan 18 290 1.4× 216 1.1× 548 3.2× 58 0.5× 394 3.7× 41 963
Shu-Hong Li China 8 145 0.7× 313 1.6× 73 0.4× 102 0.9× 204 1.9× 9 768
Braulio Martínez‐Benítez Mexico 15 199 0.9× 119 0.6× 102 0.6× 45 0.4× 156 1.5× 72 651
Hucheng Ma China 11 90 0.4× 165 0.8× 209 1.2× 46 0.4× 211 2.0× 16 503
Tetsuya Yasunaka Japan 20 622 3.0× 153 0.8× 584 3.4× 83 0.7× 262 2.4× 72 1.1k
Fabian Benz Germany 16 267 1.3× 541 2.7× 135 0.8× 575 5.2× 157 1.5× 27 1.1k
Toshinori Totsugawa Japan 21 172 0.8× 281 1.4× 302 1.8× 44 0.4× 734 6.9× 125 1.3k

Countries citing papers authored by Qingchun Fu

Since Specialization
Citations

This map shows the geographic impact of Qingchun Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingchun Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingchun Fu more than expected).

Fields of papers citing papers by Qingchun Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingchun Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingchun Fu. The network helps show where Qingchun Fu may publish in the future.

Co-authorship network of co-authors of Qingchun Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingchun Fu. A scholar is included among the top collaborators of Qingchun Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingchun Fu. Qingchun Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jinyu, Tiantian Hu, Hao Wang, et al.. (2025). Unveiling the clinical spectrum of Porto-Sinusoidal Vascular Disorder (PSVD) with chronic HBV infection: insights from a retrospective Chinese cohort. Digestive and Liver Disease. 57(9). 1794–1801.
2.
Jin, Yinpeng, Rongfeng Shi, Tangkai Qi, et al.. (2023). Adipose-derived stem cells show hepatic differentiation potential and therapeutic effect in rats with acute liver failure. Acta Biochimica et Biophysica Sinica. 55(4). 601–612. 4 indexed citations
3.
Gillessen, Anton, Francesco Angelico, Jun Chen, et al.. (2022). Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations. SHILAP Revista de lepidopterología. 1(5). 882–893. 7 indexed citations
4.
5.
Qu, Ying, Yanyan Song, Chengwei Chen, et al.. (2021). Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Clinical and Translational Gastroenterology. 12(4). e00323–e00323. 36 indexed citations
6.
Fu, Xiutao, et al.. (2020). miR-20a-5p/TGFBR2 Axis Affects Pro-inflammatory Macrophages and Aggravates Liver Fibrosis. Frontiers in Oncology. 10. 107–107. 46 indexed citations
7.
Li, Qiang, Weixia Li, Yinpeng Jin, et al.. (2020). Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study. Infectious Diseases and Therapy. 9(4). 823–836. 52 indexed citations
8.
Zhu, Mingyu, Mingjie Yao, Yiwei Lu, et al.. (2019). Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study. Journal of Clinical and Translational Hepatology. 7(X). 1–9. 9 indexed citations
9.
Wu, Yinxia, Mingliang Cheng, Chengwei Chen, et al.. (2019). [Experimental study of silybin-phospholipid complex intervention on amiodarone-induced fatty liver in mice].. PubMed. 27(1). 45–50. 3 indexed citations
10.
Li, Hongchao, Yiwen Zhou, Bohong Gu, et al.. (2018). Therapeutic Potential of Human Adipose-Derived Stem Cell Exosomes in Stress Urinary Incontinence – An in Vitro and in Vivo Study. Cellular Physiology and Biochemistry. 48(4). 1710–1722. 59 indexed citations
11.
Jin, Yinpeng, Junyi Wang, Hongchao Li, et al.. (2018). Extracellular Vesicles Secreted by Human Adipose-derived Stem Cells (hASCs) Improve Survival Rate of Rats with Acute Liver Failure by Releasing lncRNA H19. EBioMedicine. 34. 231–242. 61 indexed citations
12.
Gao, Shuling, et al.. (2016). High Concentration Polymer Flooding Field Test With Well Infilling to Change Fluid Flowing Direction After Polymer Flooding. SPE EOR Conference at Oil and Gas West Asia. 11 indexed citations
13.
Gao, Yueqiu, Wenhong Zhang, Ping Xu, et al.. (2015). [Cholestasis morbidity rate in first-hospitalized patients with chronic liver disease in Shanghai].. PubMed. 23(8). 569–73. 10 indexed citations
14.
Chen, Guangfeng, Yinpeng Jin, Xiujuan Shi, et al.. (2015). Adipose-derived stem cell-based treatment for acute liver failure. Stem Cell Research & Therapy. 6(1). 40–40. 38 indexed citations
15.
Fu, Qingchun, et al.. (2012). [Set up drug lymphocyte stimulation test (3H-TdR) and observe its application in drug-induced liver injury].. PubMed. 20(3). 190–2. 3 indexed citations
16.
Li, Xinhua, Yi Lu, Yun Ling, et al.. (2011). Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations. BMC Medical Genetics. 12(1). 6–6. 39 indexed citations
17.
Wang, Xiaojin, et al.. (2011). [Antiviral drugs combined with the Denver tube in the treatment of HBV-related cirrhosis refractory ascites: two cases report].. PubMed. 19(12). 947–8.
18.
Qiu, Dekai, Qixia Wang, Hui Wang, et al.. (2010). Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. Journal of Hepatology. 54(2). 340–347. 68 indexed citations
19.
Liu, Bo, et al.. (2009). [Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B].. PubMed. 17(7). 505–8. 7 indexed citations
20.
Lu, Lungen, Minde Zeng, Yimin Mao, et al.. (2003). Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial. World Journal of Gastroenterology. 9(11). 2480–2480. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianbao Kong Breakdown of academic impact, for papers by Melitta Penz-Österreicher Breakdown of academic impact, for papers by Kang He Breakdown of academic impact, for papers by Akihiko Ohno Breakdown of academic impact, for papers by Shu-Hong Li Breakdown of academic impact, for papers by Braulio Martínez‐Benítez Breakdown of academic impact, for papers by Hucheng Ma Breakdown of academic impact, for papers by Tetsuya Yasunaka Breakdown of academic impact, for papers by Fabian Benz Breakdown of academic impact, for papers by Toshinori Totsugawa
Rankless by CCL
2026